Abstract: A method for recovering a titanium compound includes bringing a waste solution containing a titanium alkoxide into contact with a halogenating agent to convert at least a part of the titanium alkoxide to a titanium halide, and then distilling the solution containing the titanium halide to recover the titanium halide from the solution, or the method includes distilling a waste solution containing a titanium alkoxide and a titanium halide to recover at least a part of the titanium halide from the waste solution, bringing a residue in a distiller after the distillation into contact with a halogenating agent to convert at least a part of the titanium alkoxide to a titanium halide, and distilling the solution containing the titanium halide to recover the titanium halide from the solution. The method can recover an increased amount of a titanium compound from a waste solution containing a titanium alkoxide.

Abstract: The method for recovering a titanium compound according to the invention comprises bringing a waste solution containing a titanium alkoxide into contact with a halogenating agent to convert at least apart of the titanium alkoxide to a titanium halide and then distilling the solution containing the titanium halide to recover the titanium halide from the solution, or comprises distilling a waste solution containing a titanium alkoxide and a titanium halide to recover at least a part of the titanium halide from the waste solution, bringing a residue in distiller given after the distillation into contact with a halogenating agent to convert at least a part of the titanium alkoxide to a titanium halide, and distilling the solution containing the titanium halide to recover the titanium halide from the solution. According to the method of the invention, a larger amount of a titanium compound can be recovered from a waste solution containing a titanium alkoxide.

Abstract: The present invention relates to pyrimidine compounds represented by the formula ##STR1## (wherein X is a substituted or a cyclic amino group and Y is a substituted amino group or a substituted carbonyl group) or their pharmaceutically acceptable salts, and a therapeutic agent for neurological diseases comprising the compounds.These compounds are useful for treatment of various disorders in nervous systems since they are effective on growth of neurons and promotion of the formation and elongation of neutrites.

Abstract: 2,6-di-, 2,4,6-, 2,5,6-tri- or 2,4,5,6-tetra-substituted pyrimidines, and 2,6-di-substituted pyridines. These compounds are useful for treatment of neurological deseases.

Abstract: Amine represented by the following formula (1), or their acid addition salts or their quaternary ammonium salts. ##STR1## The amines of formula (1) or their pharmaceutically acceptable acid addition salts or quaternary ammonium salts are useful for the treatment and prevention of heart diseases of animals, particularly arrhythima, myocardial infarction, angina pectoris and heart failure and psychoneurological diseases.

Abstract: Discloses indan derivatives represented by the general formula [1] ##STR1## wherein R is a lower alkoxy group, a phenoxy group, ##STR2## whereupon R.sup.1 and R.sup.2 are, respectively, a hydrogen atom, a lower alkyl, lower alkenyl, phenyl, or phenyl group substituted by halogen atoms, or a monopholino group.The indan derivatives demonstrated satisfactory results in respect of a weeding effect and safety in practical use.

Abstract: A pharmaceutical composition comprising a pyrimidine represented by the following formula ##STR1## wherein R.sup.1 represents a hydrogen atom, an acyl group having 2 to 4 carbon atoms, an alkoxycarbonyl group having 2 to 5 carbon atoms, an alkoxycarbonylmethyl group having 3 to 5 carbon atoms, a 3,4-dimethoxybenzoyl group or a 3,4-methylenedioxybenzyl group,R.sup.2 represents a hydrogen atom, an amino group, a monoalkylamino group having 1 to 4 carbon atoms, an alkoxy group having 1 to 5 carbon atoms or an alkoxycarbonyl group having 2 to 4 carbon atoms,R.sup.3 represents a hydrogen atom, an alkoxycarbonyl group having 2 to 4 carbon atoms, a dialkylaminocarbonyl group having 1 to 9 carbon atoms in each alkyl moiety, an alkoxy group having 1 to 5 carbon atoms, or a hydroxyethyl group, R.sup.2 and R.sup.3, together with the carbon atoms to which they are bonded, may form a 5- to 7-membered carbocyclic ring or a heterocyclic ring having N, O or S as the hetero atom, and R.sup.

Abstract: The present invention relates to novel 2-piperazinopyrimidine derivatives represented by the following general formula [I] which are useful as, for example, an active ingredient of herbicides ##STR1## wherein R.sup.1 is a hydrogen atom or an aralkyl group and Y is one of the groups represented by the following general formulas [II] to [VII] ##STR2## (wherein a and b are positions to be bound to positions 4 and 5 of the pyrimidine ring of the formula [I], respectively; l.sub.1 and l.sub.2 each are an integer of 2 to 4; l.sub.3 is 2 or 0; l.sub.4 is 0 or 1, provided that l.sub.4 is 0 when l.sub.3 is 2 and l.sub.4 is 1 when l.sub.3 is 0; l.sub.5 is 2 or 3; l.sub.6 is 1 or 2; l.sub.7 is 2 or 3; R.sup.2 is a hydroxyl group or a toluenesulfonyloxy group; and R.sup.3, R.sup.4, R.sup.5, R.sup.6 and R.sup.7 each are a hydrogen atom or a lower alkyl group).

Abstract: Disclosed herein is an antihypertensive preparation containing, as an active component, a novel quinazoline derivative represented by the following general formula or a salt thereof: ##STR1## wherein R.sup.100 means a hydrogen atom or methoxy group, R.sup.200 and R.sup.300 denote individually a hydrogen atom or lower alkoxy group, R.sup.400 is a hydrogen atom or amino group, l stands for 2 or 3, and Het is a specific hetero ring group.